A systematic review and meta-analysis on the risk factors of acute myeloid leukemia

被引:12
|
作者
Guo, Yanrong [1 ]
Wang, Wenwen [1 ]
Sun, Huali [2 ]
机构
[1] Taizhou Cent Hosp, Dept Hematol, Taizhou Univ Hosp, Taizhou, Peoples R China
[2] Taizhou Cent Hosp, Radiotherapy Sect, Taizhou Univ Hosp, 999,Donghai Ave, Taizhou, Peoples R China
关键词
Acute myeloid leukemia (AML); family tumor history; hepatitis B virus infection rate (HBV infection rate); hepatitis C virus infection rate (HCV infection rate); environmental exposure rate; CHILDHOOD ACUTE-LEUKEMIA; FAMILY-HISTORY; HEPATITIS-B; CANCER; EXPOSURE; CHILDREN;
D O I
10.21037/tcr-22-27
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Acute myeloid leukemia (AML) is one of the main types of leukemia that threatens the life and health of patients. A large number of clinical studies have been conducted on the etiology of the disease. However, there are few evidence-based medical studies and no definitive treatment guidelines. Methods: Related articles were searched from Medline, Excerpta Medica Database (EMBASE), EBSCO, OVID, Chinese Biology Medicine Disc (CBMDISC), and Wanfang databases. The search time limit was from the establishment of the database to September 2021. The search terms were as follows: acute myeloid leukemia, AML, electromagnetic field, case-control study, cohort study, and risk factors. All literatures were included according to PICOS standards, and the risk of deviation and literature quality were assessed. RevMan 5.3 software was used for meta-analysis. Results: The 10 articles included were of high quality and low bias risk. The research results showed that compared with healthy people, among the risk factors for AML, family tumor history [risk ratio (RR) =0.98; 95% confidence interval (CI): (0.57, 1.69); Z=0.08; P=0.94] and the hepatitis B virus (HBV) infection rate [odds ratio (OR) =1.34; 95% CI: (0.57, 3.13); Z=0.68; P=0.50] showed no significant differences, but the hepatitis C virus (HCV) infection rate [OR =1.60; 95% CI: (1.17, 2.19); Z=2.92; P=0.003] and environmental exposure rate [OR =1.49; 95% CI: (1.01, 2.21); Z=2.02; P=0.04] increased significantly. Conclusions: A total of 10 articles were included to analyze AML risk factors and related content. The results suggested that HCV infection and environmental exposure history such as home decoration were risk factors for AML.
引用
收藏
页码:796 / 804
页数:9
相关论文
共 50 条
  • [21] Venetoclax and azacitidine compared with azacitidine monotherapy for acute myeloid leukemia patients: A systematic review and meta-analysis
    Noersamsjah, A. M.
    Lim, Y.
    Chandra, A. I.
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1603 - S1604
  • [22] Busulfan versus treosulfan conditioning for acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis
    Rehman, Mohammad Ebad Ur
    Suheb, Mahammed Khan
    Umar, Haddaya
    Naaz, Fnu Farheen
    Shah, Zunairah
    Khan, Zarak
    Cheema, Huzaifa Ahmad
    Basit, Jawad
    Fazal, Faizan
    Maqbool, Shahzaib
    Farhan, Muhammed
    Dhama, Kuldeep
    Akbar, Usman Ali
    Iftikhar, Raheel
    Iftikhar, Ahmad
    Anwer, Faiz
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Benchmarking treatment effects for patients over 70 with acute myeloid leukemia: A systematic review and meta-analysis
    Reljic, Tea
    Sehovic, Marina
    Lancet, Jeffrey
    Kim, Jongphil
    Al Ali, Najla
    Djulbegovic, Benjamin
    Extermann, Martine
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (08) : 1293 - 1308
  • [24] Conventional post-remission therapy in adult acute myeloid leukemia - a systematic review/meta-analysis
    Magina, N.
    Pregartner, G.
    Berghold, A.
    Sill, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S385 - S385
  • [25] COMPARISON OF AZACITIDINE AND DECITABINE FOR THE TREATMENT OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS
    Saiz-Rodriguez, M.
    Cuevas, B.
    Martinez-Cuadron, D.
    Campuzano, V
    Cuevas, M., V
    Hermida, G.
    Alvarez, R.
    Gonzalez-Lopez, T. J.
    Diaz-Galvez, F. J.
    De Vicente, P.
    Montesinos, P.
    Labrador, J.
    HAEMATOLOGICA, 2020, 105 : 56 - 57
  • [26] Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis
    He, Pin-Fang
    Zhou, Jing-Dong
    Yao, Dong-Ming
    Ma, Ji-Chun
    Wen, Xiang-Mei
    Zhang, Zhi-Hui
    Lian, Xin-Yue
    Xu, Zi-Jun
    Qian, Jun
    Lin, Jiang
    ONCOTARGET, 2017, 8 (25) : 41498 - 41507
  • [27] Venetoclax combined chemotherapy versus chemotherapy alone for acute myeloid leukemia: a systematic review and meta-analysis
    Zhu, Jingkui
    Fan, Jixin
    Xie, Tiantian
    Zhao, Haiqiu
    Lu, Runqing
    Zhang, Yinyin
    Li, Yingmei
    Xie, Xinsheng
    Wan, Dingming
    Jiang, Zhongxing
    He, Fei
    Guo, Rong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [28] The Role of Anti-CD33 for the Treatment of Acute Myeloid Leukemia - Systematic Review and Meta-Analysis
    Gurion, Ronit
    Gafter-Gvili, Anat
    Ram, Ron
    Vidal, Liat
    Raanani, Pia
    Shpilberg, Ofer
    BLOOD, 2012, 120 (21)
  • [29] The prognostic value of plasma fibrinogen level in patients with acute myeloid leukemia: a systematic review and meta-analysis
    Zhang, Ziyan
    Zhang, Rui
    Qi, Jiaqian
    Miao, Wenjing
    Fang, Kun
    Ruan, Changgeng
    Wu, Depei
    Han, Yue
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2682 - 2691
  • [30] Prognostic significance of ASXL1 mutations in acute myeloid leukemia: A systematic review and meta-analysis
    Sheikhi, Maryam
    Rostami, Mehrdad
    Ferns, Gordon
    Ayatollahi, Hossein
    Siyadat, Payam
    Ayatollahi, Yasamin
    Khoshnegah, Zahra
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2024, 15 (02) : 202 - 214